News

In March 2020, the therapy has the potential to become the first approved for the rare autoimmune disorder.

A research letter published in JAMA Network Open is painting a clearer picture of how the introduction of a biosimilar impacts trends in pricing, cost, and discounts related to the originator biologic.

The authorization could allow other technology for diabetes to go through the review process more quickly.

The new indication will allow the longtime ALS therapy to be used among the 85% of patients required to use PEG due to dysphagia.

The once-daily therapy has been previously approved for treatment of adults with difficult-to-treat rheumatoid arthritis or psoriatic arthritis.

System usability scale scores decreased for 44% of vendors from 2014–2015.

The tool provided accurate information for ambulatory procedures, from costs to additional services.

The approval comes 4 months following a Complete Response Letter was submitted and successfully disputed, to Sarepta Therapeutics.

In a new study, investigators suggest coffee may be used in prevention strategies for chronic kidney disease.

The FDA has granted marketing authorization for the GSP Neonatal Creatine Kinase-MM to aid physicians in screening newborns for Duchenne Muscular Dystrophy.

Investigators show how sleep deprivation has a cognitive impact the following day.

A novel, multichannel AI model outperformed 3 single-channel models in a randomized trial.

A look back at how chronic disease management, physician shortage, and newer therapies shaped the modern care team.

A meta-analysis of more than 1 million patients and 2 dozen studies has revealed patients over 60 with hypothyroidism were at a 26% greater chance of all-cause mortality.

In a comparison, investigators find that surgery is more successful in treating GERD patients who do not respond to protein pump inhibitors.

An analysis of the Dongfeng-Tongi cohort has revealed sleeping more than 9 hours per night or taking midday naps lasting longer than 90 minutes was associated with an increase in risk of total stroke.

The platform could allow clinicians to provide more individualized care to patients.

How primary care fits into the scheme of patient management, and what new therapies may mean for atopic dermatitis.

A study from SUNY University at Buffalo has found adherence to a Western diet could contribute to the development of late age-related macular degeneration.

A new study of more than 60,000 individuals over the course of a decade suggests non-Hispanic blacks were less likely to use and see benefits from low-dose aspirin in the same way as non-Hispanic whites.

The treatment can be used for a diverse population of women with the condition.

Nearly one dozen therapies have reached the psoriasis market, and the new standard is at least 90% skin clearance—an achievement previously unmet.

In the last decade, investigators have put an emphasis on better disease monitoring for digestive diseases. The result has been better patient outcomes.

How technology, innovation, and preventive care drove the last 10 years of improved public heart health.

Over 4 decades, the lessons I learned from my first chief of medicine have never wavered in value.

A new analysis has found the switch to the “increased-risk” donor classification by the US Public Health Service has had minimal impact on outcomes of lung transplants.

Investigators examine data from 13,200 adolescents to discover the association between bullying perpetration with internalizing problems.

A systematic review shows women are putting their offspring at risk of various chronic conditions, based on their improper diets.